In MM, SPRED1 loss rarely co-occurs with BRAF mutations, NRAS mutations, or NF1 inactivation mutations (6), indicating those alterations play similar roles in activating MAPK pathway signaling in MM. The gene discussed is NF1; the disease is Miyoshi myopathy.